Actieve functies van Devon Cayer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Myi Diagnostics & Discovery, Inc.
 Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 08-09-2015 | - |
| Oprichter | 08-09-2015 | - |
Loopbaan van Devon Cayer
Eerdere bekende functies van Devon Cayer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
1859, Inc.
 1859, Inc. BiotechnologyHealth Technology 1859, Inc. operates as a biotechnology company focuses on discovery and development of next-generation therapeutics. The company was founded by Devon Cayer, Andrew MacConnell, Ramesh Ramji, and Sara Thrall and is headquartered in Del Mar, CA. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - | |
| Oprichter | - | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Myi Diagnostics & Discovery, Inc.
Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Health Technology |
1859, Inc.
1859, Inc. BiotechnologyHealth Technology 1859, Inc. operates as a biotechnology company focuses on discovery and development of next-generation therapeutics. The company was founded by Devon Cayer, Andrew MacConnell, Ramesh Ramji, and Sara Thrall and is headquartered in Del Mar, CA. | Health Technology |
- Beurs
- Insiders
- Devon Cayer
- Ervaring
